Almina Erdem

Senior Cardiology Trainee / Istanbul-Turkey

[Almina Erdem @AlminaErdem]

Excited to share two important milestones in my career: I have completed my Cardiology Specialty Training and passed the European Examination in Core Cardiology (EECC). Looking forward to the next chapter in interventional cardiology. #EECC #CardioX

[Almina Erdem @AlminaErdem]

Happy to have attended the EAPCI 2026 Summit in Munich 🥨 , which welcomed us with beautiful snowy days. It was a great opportunity to connect with inspiring experts, learn from outstanding faculty, and take part in highly valuable workshops. @escardio @EAPCIPresident #EAPCI2026

[Almina Erdem @AlminaErdem]

@EchoSoliman @escardio It’s a real pleasure and a privileage to meet you. 🙏🏻

[Almina Erdem @AlminaErdem]

Proud to have presented my work on ‘Epicardial Adipose Tissue Thickness as an Early Predictor of Metabolic Syndrome in Young People without Obesity’ once again at #ESCCongress2025 @escardio

[Almina Erdem @AlminaErdem]

Thrilled to share that our work has once again been accepted for presentation at #ESC2025 ! Grateful for the opportunity to contribute to the world’s leading cardiology congress. @escardio #ESCCongress #WCCardio

[日本循環器学会 情報広報部会 @JCIRC_IPR]

Artificial Intelligence helps predicting short-term mortality of patients with acute pulmonary embolism better than current clinical guidelines.
By Vedat Cicek @VedatCicek_MD
https://t.co/7DcxRcf3Tm
#circ_j #CardioX

[Berke Cenktug Korucu, MD @BerkeKorucuMD]

Thanks to my co-authors and #AHA24 community, a memorable day at Chicago! @Tufannar7 @AlminaErdem @leventpy @mertilkerh @AHAScience

[büşra🪭 @theheartandhead]

#turkishwomenareindanger

[Türk Kardiyoloji Derneği @TKDResmi]

Londra’da düzenlenen ESC Kongresi’nde 50’den fazla değerli üyemiz, bilimsel programa katkı sağlayarak ülkemizi en iyi şekilde temsil etti.
Klinik vaka bildirilerinde Türkiye’nin ilk 10 içinde yer alması ise hepimiz için büyük bir gurur kaynağı!❤️

#TürkKardiyolojiDerneği #ESC2024

[Almina Erdem @AlminaErdem]

@thecardiofellow @escardio @NurglKeser6 Thank you Gwen, congratulations too for your presentation 🫀

[Almina Erdem @AlminaErdem]

In my last presentation at the #ESCCongress I had the chance to talk about the relationship between gender differences and cardiovascular risk factors, coronary obstruction localization. @escardio @NurglKeser6

[Almina Erdem @AlminaErdem]

Second day of the #ESCCongress 🫀 I had chance to present our meta analysis about the effects of SGLT2 inhibitors on right heart functions. @escardio @Tufannar7

[Almina Erdem @AlminaErdem]

First session of #ESCCongress @escardio

[Almina Erdem @AlminaErdem]

Great start to the #ESCCongress
The importance of mentorship programs in increasing the number and representation of women leaders in cardiology is undeniable. Today's conference highlighted this, it's time to take action to see more women leaders! #RISE2024 @WomenAs1 @escardio

[Almina Erdem @AlminaErdem]

👏🏻

[Tufan Cinar @Tufannar7]

I am very happy to announce that my abstract has been accepted for presentation at AHA’s annual Scientific Sessions 2024. I want to thank all my co-authors .Looking forward to meeting the top global leaders in cardiovascular and brain health. @American_Heart @mertilkerh.

[Almina Erdem @AlminaErdem]

@NBegumOzturkMD @AASLDtweets @AASLDFoundation Congratulations Begum 👏🏻 💕

[Tufan Cinar @Tufannar7]

However, as there is a limited studies included this meta-analysis, further studies are need to elucidute the exact effects of SGLT-2 inhibitors.

[Tufan Cinar @Tufannar7]

Our recent meta-analysis investigating the effects of SGLT-2 inhibitors on R heart functions has been published in Kardiologica Polska. This analysis showed that SGLT-2 inhibitors might have benificial effects on R heart functions in addition to L heart functions.

[Tufan Cinar @Tufannar7]

Cinar T, Saylik F, Cicek V, Pay L, Khachatryan A, Alejandro J, Erdem A, Hayiroglu MI. Effects of SGLT2 inhibitors on right ventricular function in heart failure patients: Updated meta-analysis of the current literature. Kardiol Pol. 2024;82(4):416-422. doi: 10.33963/v.phj.100199.